These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3904427)

  • 21. Aluminium in renal disease: current knowledge and future developments.
    Starkey BJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():337-44. PubMed ID: 3310831
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.
    Donnelly SM; Smith EK
    Am J Kidney Dis; 1990 Nov; 16(5):487-90. PubMed ID: 2239943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
    G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis.
    Chang TM; Barre P
    Lancet; 1983 Nov; 2(8358):1051-3. PubMed ID: 6138600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of erythroid colony forming cells in sera of azotemic patients with anemia of renal disease.
    Rege AB; Ohno Y; Barona J; Fisher JW
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():189-93. PubMed ID: 756044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminium-induced anaemia in haemodialysis patients.
    McGonigle RJ; Parsons V
    Nephron; 1985; 39(1):1-9. PubMed ID: 3969184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detoxification in hemosiderosis.
    Simon P
    Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypochronic anemia in chronic renal failure--role of aluminium.
    Agarwal SK
    J Assoc Physicians India; 2000 May; 48(5):549-50. PubMed ID: 11273162
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney.
    Jeffery EH; Abreo K; Burgess E; Cannata J; Greger JL
    J Toxicol Environ Health; 1996 Aug; 48(6):649-65. PubMed ID: 8772804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aluminum on hematopoiesis.
    Drüeke TB; Lacour B; Touam M; Jucquel JP; Plachot JJ; Cournot-Witmer G; Galle P
    Kidney Int Suppl; 1986 Feb; 18():S45-8. PubMed ID: 3457995
    [No Abstract]   [Full Text] [Related]  

  • 33. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA; Ford DM; Gaston CE; Sedman AB; Huffer WE; Lum GM
    Pediatrics; 1986 Oct; 78(4):651-5. PubMed ID: 3763276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The anemia of chronic renal insufficiency].
    Danieli G; Montroni M
    G Clin Med; 1966 Nov; 47(11):1065-110. PubMed ID: 5999048
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC; Huang TP; Chen TW; Yang WC
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P; Gmeiner R; Beck G; König P
    Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.